Research Article

A Pyroptosis-Based Prognostic Model for Immune Microenvironment Estimation of Hepatocellular Carcinoma

Figure 7

Drug sensitivity and immune checkpoint gene expression of high-risk and low-risk groups in TCGA. (a) Sorafenib IC50 comparison. (b–g) The immune checkpoint expression comparison, including PDCD1, CD274, CTLA4, HAVCR2, LAG3, and TIGIT (, , and ).
(a)
(b)
(c)
(d)
(e)
(f)
(g)